Bolder BioTechnology | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

12,136 results for “Bolder BioTechnology”

Trials

View all 6796 →

BIOtechnology Applied to Renal TRansplantation With IMmunobiogram

443 participants · First posted Apr 18, 2023

Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)

17 participants · First posted Jul 11, 2007

Neoadjuvant/Adjuvant Chemotherapy, Vaccine & Adjuvant Radiation Therapy in p53-Overexpressing Stage III Breast Cancer

24 participants · First posted May 19, 2004

Drugs

View all 789 →

Pegylated-somatropin(Bolder BioTechnology)

Peginterferon gamma(Bolder BioTechnology)

PEGylated G-CSF(Bolder BioTechnology)

Organizations

View all 269 →

Golden Biotechnology Corporation

China

Puma Biotechnology

United States

MAIA Biotechnology

United States

News

View all 4282 →

NIAID Continues Funding for Bolder BioTechnology's BBT-059 as Radiation Countermeasure

Puma Biotechnology Joins NASDAQ Biotechnology Index Following Commercial Success and Clinical Progress

Oman Moves Closer to Adopting National Biotechnology Strategy

Page 1 of 1214